_version_ |
1809901316248436736
|
annif_keywords_txtF_mv |
breast cancer
cancerous diseases
forecasts
laboratories
diagnostics
|
annif_uris_txtF_mv |
http://www.yso.fi/onto/yso/p20019
http://www.yso.fi/onto/yso/p678
http://www.yso.fi/onto/yso/p3297
http://www.yso.fi/onto/yso/p8598
http://www.yso.fi/onto/yso/p416
|
author |
Lehto, Niina
|
author2 |
Matemaattis-luonnontieteellinen tiedekunta
Faculty of Sciences
Bio- ja ympäristötieteiden laitos
Department of Biological and Environmental Science
Jyväskylän yliopisto
University of Jyväskylä
Solu- ja molekyylibiologia
Cell and molecular biology
4013
|
author_facet |
Lehto, Niina
Matemaattis-luonnontieteellinen tiedekunta
Faculty of Sciences
Bio- ja ympäristötieteiden laitos
Department of Biological and Environmental Science
Jyväskylän yliopisto
University of Jyväskylä
Solu- ja molekyylibiologia
Cell and molecular biology
4013
Lehto, Niina
|
author_sort |
Lehto, Niina
|
building |
Jyväskylän yliopisto
JYX-julkaisuarkisto
|
datasource_str_mv |
jyx
|
department_txtF |
Bio- ja ympäristötieteiden laitos
|
faculty_txtF |
Matemaattis-luonnontieteellinen tiedekunta
|
first_indexed |
2020-12-15T21:04:19Z
|
format |
Pro gradu
|
format_ext_str_mv |
Opinnäyte
Pro gradu
|
free_online_boolean |
1
|
fullrecord |
<?xml version="1.0"?>
<qualifieddc schemaLocation="http://purl.org/dc/terms/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dcterms.xsd http://purl.org/dc/elements/1.1/ http://dublincore.org/schemas/xmls/qdc/2006/01/06/dc.xsd"><title>Comparison of two laboratory developed PD-L1 assays with clinically approved Ventana SP142 assay and prognostic significance of PD-L1-positivity and immune cell densities in triple-negative breast cancer patients</title><creator>Lehto, Niina</creator><contributor type="tiedekunta" lang="fi">Matemaattis-luonnontieteellinen tiedekunta</contributor><contributor type="tiedekunta" lang="en">Faculty of Sciences</contributor><contributor type="laitos" lang="fi">Bio- ja ympäristötieteiden laitos</contributor><contributor type="laitos" lang="en">Department of Biological and Environmental Science</contributor><contributor type="yliopisto" lang="fi">Jyväskylän yliopisto</contributor><contributor type="yliopisto" lang="en">University of Jyväskylä</contributor><contributor type="oppiaine" lang="fi">Solu- ja molekyylibiologia</contributor><contributor type="oppiaine" lang="en">Cell and molecular biology</contributor><contributor type="oppiainekoodi">4013</contributor><subject type="yso">rintasyöpä</subject><subject type="yso">rinnat</subject><subject type="yso">immuunijärjestelmä</subject><subject type="yso">immunologia</subject><subject type="yso">diagnostiikka</subject><subject type="yso">breast cancer</subject><subject type="yso">breasts</subject><subject type="yso">immune system</subject><subject type="yso">immunology</subject><subject type="yso">diagnostics</subject><available>2020-12-15T09:36:00Z</available><issued>2020</issued><type lang="fi">Pro gradu -tutkielma</type><type lang="en">Master’s thesis</type><identifier type="uri">https://jyx.jyu.fi/handle/123456789/73209</identifier><identifier type="urn">URN:NBN:fi:jyu-202012157155</identifier><language type="iso">en</language><rights type="copyright" lang="fi">Julkaisu on tekijänoikeussäännösten alainen. Teosta voi lukea ja tulostaa henkilökohtaista käyttöä varten. Käyttö kaupallisiin tarkoituksiin on kielletty.</rights><rights type="copyright" lang="en">This publication is copyrighted. You may download, display and print it for Your own personal use. Commercial use is prohibited.</rights><rights type="accessrights" lang="fi">Tekijä ei ole antanut lupaa avoimeen julkaisuun, joten aineisto on luettavissa vain Jyväskylän yliopiston kirjaston arkistotyösemalta. Ks. https://kirjasto.jyu.fi/fi/tyoskentelytilat/laitteet-ja-tilat..</rights><rights type="accessrights" lang="en">The author has not given permission to make the work publicly available electronically. Therefore the material can be read only at the archival workstation at Jyväskylä University Library (https://kirjasto.jyu.fi/en/workspaces/facilities).</rights><permaddress type="urn">http://www.urn.fi/URN:NBN:fi:jyu-202012157155</permaddress><file bundle="ORIGINAL" href="https://jyx.jyu.fi/bitstream/123456789/73209/1/URN%3aNBN%3afi%3ajyu-202012157155.pdf" name="URN:NBN:fi:jyu-202012157155.pdf" type="application/pdf" length="2718480" sequence="1"/><recordID>123456789_73209</recordID></qualifieddc>
|
id |
jyx.123456789_73209
|
language |
eng
|
last_indexed |
2024-09-03T10:52:54Z
|
main_date |
2020-01-01T00:00:00Z
|
main_date_str |
2020
|
online_boolean |
1
|
online_urls_str_mv |
{"url":"https:\/\/jyx.jyu.fi\/bitstream\/123456789\/73209\/1\/URN%3aNBN%3afi%3ajyu-202012157155.pdf","text":"URN:NBN:fi:jyu-202012157155.pdf","source":"jyx","mediaType":"application\/pdf"}
|
oppiainekoodi_txtF |
4013
|
publication_first_indexed |
2020-12-15T21:04:19Z
|
publishDate |
2020
|
record_format |
qdc
|
source_str_mv |
jyx
|
spellingShingle |
Lehto, Niina
Comparison of two laboratory developed PD-L1 assays with clinically approved Ventana SP142 assay and prognostic significance of PD-L1-positivity and immune cell densities in triple-negative breast cancer patients
rintasyöpä
rinnat
immuunijärjestelmä
immunologia
diagnostiikka
breast cancer
breasts
immune system
immunology
diagnostics
|
subject_txtF |
Solu- ja molekyylibiologia
|
thumbnail |
https://jyu.finna.fi/Cover/Show?source=Solr&id=jyx.123456789_73209&index=0&size=large
|
title |
Comparison of two laboratory developed PD-L1 assays with clinically approved Ventana SP142 assay and prognostic significance of PD-L1-positivity and immune cell densities in triple-negative breast cancer patients
|
title_full |
Comparison of two laboratory developed PD-L1 assays with clinically approved Ventana SP142 assay and prognostic significance of PD-L1-positivity and immune cell densities in triple-negative breast cancer patients
|
title_fullStr |
Comparison of two laboratory developed PD-L1 assays with clinically approved Ventana SP142 assay and prognostic significance of PD-L1-positivity and immune cell densities in triple-negative breast cancer patients
Comparison of two laboratory developed PD-L1 assays with clinically approved Ventana SP142 assay and prognostic significance of PD-L1-positivity and immune cell densities in triple-negative breast cancer patients
|
title_full_unstemmed |
Comparison of two laboratory developed PD-L1 assays with clinically approved Ventana SP142 assay and prognostic significance of PD-L1-positivity and immune cell densities in triple-negative breast cancer patients
Comparison of two laboratory developed PD-L1 assays with clinically approved Ventana SP142 assay and prognostic significance of PD-L1-positivity and immune cell densities in triple-negative breast cancer patients
|
title_short |
Comparison of two laboratory developed PD-L1 assays with clinically approved Ventana SP142 assay and prognostic significance of PD-L1-positivity and immune cell densities in triple-negative breast cancer patients
|
title_sort |
comparison of two laboratory developed pd l1 assays with clinically approved ventana sp142 assay and prognostic significance of pd l1 positivity and immune cell densities in triple negative breast cancer patients
|
title_txtP |
Comparison of two laboratory developed PD-L1 assays with clinically approved Ventana SP142 assay and prognostic significance of PD-L1-positivity and immune cell densities in triple-negative breast cancer patients
|
topic |
rintasyöpä
rinnat
immuunijärjestelmä
immunologia
diagnostiikka
breast cancer
breasts
immune system
immunology
diagnostics
|
topic_facet |
breast cancer
breasts
diagnostics
diagnostiikka
immune system
immunologia
immunology
immuunijärjestelmä
rinnat
rintasyöpä
|
url |
https://jyx.jyu.fi/handle/123456789/73209
http://www.urn.fi/URN:NBN:fi:jyu-202012157155
|
work_keys_str_mv |
AT lehtoniina comparisonoftwolaboratorydevelopedpdl1assayswithclinicallyapprovedventanasp142assayan
|